Browse Articles
Discover research articles across all indexed journals
Early toxicity–driven dose modification and efficacy of adjuvant abemaciclib in high-risk HR+/HER2− early breast cancer: A real-world study in Chinese patients.
38 Background: Adjuvant abemaciclib plus endocrine therapy (ET) improves invasive disease-free survival (iDFS) in patients with high-risk hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) early breast cancer (EBC). However, Chinese patients were underrepresented in pivotal trials, and real-world evidence regarding toxicity-driven dose management and its impact on efficacy remains limited. Methods: This single-center retrospective cohort study included 130 consecutive female patients with high-risk HR+/HER2− EBC treated with adjuvant abemaciclib plus ET between December 2021 and June 2025. High-risk status was defined by Monarch-E criteria combined with real-world clinical assessment, including multigene expression assay results used to inform recurrence risk in patients not strictly meeting pathological criteria. The primary endpoint was iDFS. Secondary endpoints included overall survival (OS), safety, and dose modification patterns. Survival outcomes were estimated using the Kaplan–Meier method and Cox proportional hazards models. Results: After a median follow-up of 24.6 months, 21 iDFS events and 1 death were observed. Dose modification occurred in 28.5% of patients, with 70.3% of initial modifications occurring within the first 3 months. Most dose reductions followed a stepwise strategy to 100 mg twice daily (78.4%) and were primarily driven by adverse events, particularly diarrhea (53.1%), of which 82.4% were grade 3. Grade ≥3 diarrhea occurred in 25.0% of patients, and interstitial lung disease in 5.7%, which may reflect intensive real-world safety monitoring and broader diagnostic capture compared with clinical trial settings. Median iDFS was 27.5 months in the dose modification group (n=37) vs. 22.7 months in the non-modification group (n=93) (log-rank test, P =0.88), confirming no efficacy compromise from early toxicity-driven dose adjustment despite limited events. Neither lymph node burden nor Ki-67 expression showed independent prognostic significance for iDFS in univariate or multivariate analyses within this cohort (all P >0.05). Conclusions: In this real-world Chinese cohort, early toxicity-driven dose modification of adjuvant abemaciclib was not associated with inferior iDFS within the current follow-up period, supporting proactive dose management rather than treatment discontinuation. Traditional clinicopathological high-risk factors did not demonstrate independent prognostic significance, potentially due to limited sample size and events. No new safety signals were identified in this study, however, the management of diarrhea and interstitial pneumonia requires further optimization in the Chinese population.
Structural modelling of germline FOXA1 variants identified in Asian participants with incident gastrointestinal cancers from the UK Biobank.
165 Background: Interpretation of rare germline missense variants identified through population-scale exome sequencing remains challenging, particularly in under-represented ancestries. Such variants are often observed in individuals who later develop cancer, yet their biological relevance is difficult to infer from sequence data alone. FOXA1 is a pioneer transcription factor involved in chromatin regulation and epithelial differentiation, and its dysregulation has been implicated in gastrointestinal (GI) carcinogenesis. Methods: Whole-exome sequencing data from the UK Biobank were analysed to identify FOXA1 missense variants in Asian participants with incident GI cancers. Among these, 77 individuals carried one or more FOXA1 variants. Four variants (p.A83T, p.L148V, p.H387R, p.S448N), absent in Asian healthy controls, were prioritised. AlphaFold-based structural models were used to evaluate single-, dual- and multi-variant configurations using global and domain-restricted RMSD, local interaction mapping, and in silico stability prediction. Results: Across all models, the global FOXA1 architecture, including the forkhead DNA-binding domain, remained preserved, indicating structural robustness to multiple substitutions. Each variant induced localized perturbations affecting residue packing, polarity, and interaction networks without evidence of global unfolding. Variants in flexible regulatory regions (A83T, S448N) altered local interaction environments, while substitutions near structured regions (L148V) and in loop-proximal segments (H387R) modulated hydrophobic packing and surface electrostatics. Combined variant models demonstrated spatially segregated effects without additive destabilisation. Conclusions: Structural modelling provides mechanistic context for germline FOXA1 variants identified in the UK Biobank cohort. The preserved global fold with localized perturbations is consistent with region-specific conformational modulation rather than global structural collapse. Such structure-based interpretation may help prioritise rare germline variants for downstream functional investigation and improve understanding of how these variants may contribute to cancer biology within precision oncology frameworks.
Interpretable spatial multi-omics data integration and dimensionality reduction with SpaMV
Nucleoside 3′-Phosphorofluoridates for P(V)-Based Oligonucleotide Synthesis
Nine keys for successful interprofessional collaboration Based on observing facilitators and barriers during different types of treatment meetings: A qualitative study
Introduction The increasing prevalence of multimorbidity requires effective collaboration between health professionals. Both interprofessional (IP) and multidisciplinary (MD) collaboration can be used for this purpose. IP collaboration refers to professionals working together toward a common patient-centred goal. In contrast, MD collaboration involves health professionals advocating for their own specialty, which may result in different disease-centred goals for the same patient. This study aims to evaluate and compare these two types of collaboration and develop recommendations for successful collaboration for patients with multimorbidity. Methods This qualitative study employed a rapid ethnographic non-participatory approach. We observed IP and MD treatment meetings using video and audio recordings to identify factors that might influence collaboration between health professionals. Data were analysed iteratively by multiple researchers using a thematic and conventional content analysis. Results There were clear differences between the observed meetings. The IP meetings had a roundtable setting, designated chair, discussions around a common patient-centred goal, active participants, and a relaxed atmosphere that facilitated interprofessional learning. Conversely, the MD meetings had a theatre design, disease-centred discussion, more passive participants, and a less relaxed atmosphere with fewer opportunities for learning. Five participants attended both settings. These participants were more actively engaged and contributed more to interprofessional learning in the IP meetings than in the MD meetings. Conclusion This study showed multiple factors that may influence collaboration and participants’ behaviour, particularly regarding active participation, learning, and patient-centred care. These factors were translated into nine keys for optimizing collaboration, which could support improvement in collaborative practice.
A compact Kolmogorov–Arnold network mixer for long-term time series forecasting
Abstract Long-term time series forecasting (LTSF) underpins critical applications from energy management to weather prediction, yet achieving reliable multi-step-ahead accuracy remains challenging. Existing LTSF approaches, dominated by MLP- and Transformer-based architectures, either rely on simple linear mappings or introduce increasingly complex hand-crafted inductive biases, raising the question of whether a more expressive nonlinear modeling core could offer a useful alternative. In this work, we investigate whether Kolmogorov–Arnold Networks (KANs), which use learnable basis functions on network edges to model nonlinear relationships, can serve as effective modeling components for LTSF, and under which design choices they are most useful. Motivated by this question, we propose KANMixer, a compact KAN-centered architecture consisting of a multi-scale pooling frontend, KAN-based temporal mixing blocks, and KAN-based prediction heads. Unlike KAN-based forecasting models that combine KAN with decomposition-heavy or mixture-based pipelines, KANMixer is designed as a simple and controlled architecture for examining the role of KAN components in LTSF. Under a unified five-run reproduction protocol on seven standard benchmarks, KANMixer achieves competitive performance against representative LTSF baselines, especially on ETT-style datasets, while showing dataset-dependent limitations. Additional statistical tests, ablations, efficiency profiling, Gaussian-noise evaluation, and hyperparameter sensitivity analysis show that the practical value of KAN depends on basis-function choice, architectural placement, and computational constraints. These results suggest that KANs are promising but not plug-and-play components for LTSF, and that their benefits should be evaluated together with robustness and efficiency trade-offs.
Regulation Roles of <i>p</i> ‐Block Elements in Lithium Layered Oxide Cathodes: Recent Progress and Perspectives
ABSTRACT Layered oxides derived from Li x TM y O 2 (TM: Ni, Co, Mn and etc.), based on the de/intercalation mechanism, have long served as the backbone of lithium‐ion batteries (LIBs) for portable electronics, electric vehicles, and energy storage. However, the unstable structural evolution, sluggish diffusion kinetics, and detrimental interface parasitic reaction deteriorate their electrochemical performance. Due to p ‐block elements with unique electronic structures, the substitution in Li x TM y O 2 with p ‐block elements has become one of the mainstream practices. Therefore, clarifying the relationship among substitution, structure and performance is critical for rational design of high‐performance LIBs. However, a systematic review focusing on regulation roles of p ‐block elements in Li x TM y O 2 cathodes is lacking. Seeking to systematically understand the interaction between p ‐block elements with the matrix of Li x TM y O 2 cathodes, herein, we firstly outline the structure and mechanisms of Li x TM y O 2 cathodes, then highlight the internal structural degradation and external interface instability. And the performance enhancement mechanisms are emphasized in detail. Secondly, according to the order of the main group, a comprehensive review on the progress of p ‐block element substitution in Li x TM y O 2 are provided. Finally, the challenges and future perspectives are figured out, which can shed light on the design guideline of Li x TM y O 2 cathodes in the future.
Creatine metabolism regulates trophectoderm formation in early mouse embryos via an energy-cytoskeleton-YAP axis
Effect of cancer-neurons on cytotoxic NK cell exhaustion and immunotherapy resistance in gastric cancer via spatial ECM trapping and neuropeptide signaling.
147 Background: Immunotherapy resistance remains a critical clinical challenge in gastric cancer (GC). While tumor-associated neurons are emerging as key modulators of the tumor microenvironment (TME), their spatial and functional interactions with innate immune components, particularly cytotoxic natural killer cells, remain poorly defined. This study aims to delineate the spatial topography of the neural-NK cell axis to elucidate novel mechanisms of immune evasion and therapy resistance in GC. Methods: High-resolution spatial transcriptomics (Visium HD) was utilized to map the TME of GC patients treated with immunotherapy. Cohorts were stratified by clinical response (Responders vs. Nonresponders), utilizing patient IDs as the primary stratifier for robust inter-group differential comparisons. Computational spatial workflows, including neighborhood enrichment mapping, spatial cell-cell communication, and physical distance-based spatial pseudotime trajectory modeling, were employed to characterize the interactions between tumor-associated neurons and cytotoxic NK cells. Results: Spatial neighborhood enrichment mapping revealed a profound physical colocalization of cytotoxic NK cells within the immediate neural niche specifically in Nonresponders. Differential expression and communication analyses demonstrated that tumor-associated neurons construct a dense extracellular matrix "trap" by hyper-secreting COL6A3, COL14A1, and DCN, which physically anchors NK cells. Proximally trapped NK cells underwent significant transcriptional reprogramming, strongly upregulating neuropeptide and inhibitory receptors, including RAMP2, VIPR2, and TGFBR3, driven by neural-derived VIP and TGFB1 signaling. Furthermore, spatial pseudotime trajectories—modeling the physical migration of NK cells toward neurons—revealed a progressive functional collapse. Upon entering the neural niche, NK cells acquired a terminal exhaustion phenotype (upregulation of HAVCR2 and KLRC1) and exhibited a near-complete suppression of core effector weapons (downregulation of GZMB, PRF1, and IFNG). Conversely, NK cells in Responders, or those distal to nerves in Nonresponders, maintained robust cytotoxic profiles and successfully infiltrated the tumor parenchyma. Conclusions: Tumor-associated neurons orchestrate a complex "neural trap" that physically sequesters and functionally paralyzes cytotoxic NK cells via matrix remodeling and paracrine neuropeptide signaling. This neural-induced NK cell exhaustion prevents effective immune surveillance, driving an immune-excluded TME and subsequent immunotherapy resistance in GC. Targeting the neural-immune axis, particularly the VIP-RAMP2 signaling network, represents a promising therapeutic vulnerability to restore anti-tumor immunity in resistant patients.
Efficacy and safety of first-line modified docetaxel, cisplatin, and fluorouracil (mDCF) in advanced esophageal cancer: A retrospective study from Viet Nam.
97 Background: In Viet Nam, most advanced esophageal cancer patients cannot access combined immunotherapy due to high costs; thus, chemotherapy remains the primary option. Docetaxel, cisplatin, and fluorouracil (DCF) was the standard three-drug regimen, with high response rates but many side effects. The mDCF regimen has been suggested as effective and tolerable, although data are limited. This retrospective study evaluates the efficacy and safety of mDCF in Viet Nam. Methods: We conducted a retrospective study of 61 male patients with squamous cell carcinoma of the esophagus who received the mDCF regimen as first-line therapy at Viet Nam National Cancer Hospital. Patients were treated from January 2022 to January 2025. Protocol regimen: docetaxel 40 mg/m 2 , cisplatin 40 mg/m 2 , leucovorin 400 mg/m 2 , 5-FU 400 mg/m 2 IV bolus, and 5-FU 2000 mg/m 2 as a 48-hour continuous infusion, every 14 days until disease progression or unacceptable toxicity. Primary endpoints: disease control rate (DCR) and progression-free survival (PFS), secondary endpoints: overall survival (OS) and adverse events. Results: The median age was 57 (range 40-74); ECOG PS 0/1/2: 49.1%/47.5%/3.4%. Median number of cycles was 8 (range 4–17). The DCR reached 83.6%, with complete response, partial response, disease stability, and disease progression accounting for 4.9%, 55.7%, 23.0%, 16.4%, respectively. Median PFS was 6.2 months. Median OS was 12.9 months. Grade 3-4 hematologic toxicities were neutropenia, occurring in 6.5% of patients. Primary prophylactic G-CSF Granulocyte-Colony Stimulating Factor) was used in 36.1% patients. Non-hematologic adverse events were grade 1 or 2 and were manageable. Conclusions: First-line mDCF is an effective protocol with a tolerable and controllable toxicity profile for advanced esophageal cancer.
Rotational observation of kinetically hindered neutral radical pairs
Mechanical Gating of Redox Access in Molecular Electrocatalysis
An exercise-associated gut microbiota signature enhances endurance performance: A study combining a human cohort and a mice FMT model
Background The gut microbiota is closely related to exercise, but the interrelationship between the two remains elusive. In this study, we aimed to explore differences in the gut microbiota between young adults with exercise and sedentary lifestyles. In addition, we evaluated the effects of gut microbiota from these different lifestyle populations on endurance exercise capacity. Methods The exercise status and nutritional characteristics of young adults were evaluated by PARS-3 and food frequency questionnaires. The gut microbiota of young adults from exercise and sedentary lifestyle groups was analyzed by 16S rRNA analysis. Subsequently, we performed fecal bacteria transplantation (FMT) from the human donors into mice and evaluated the effects on their endurance exercise capacity. Results The exercise group exhibited significantly higher gut microbiota diversity compared to the sedentary group. Several beneficial bacteria, including Veillonella, Faecalibacterium, and Bacteroides, were enriched in the exercise group. The FMT experiment confirmed that mice receiving microbiota from the exercise group showed significantly improved endurance exercise capacity. Conclusion Young people who exercise regularly possess a more diverse gut microbiota enriched with beneficial bacteria. This exercise-associated microbiota has the potential to directly improve exercise capacity.
Influence of seismic energy dissipation technology on carbon emission of building construction
Transient Laser‐Shocked Synthesis of Amorphous Layer‐Supported Metal Nanocrystals for Efficient Nitrate Reduction
ABSTRACT Metal‐support interactions provide a powerful tool to tailor the catalytic activities of metallic catalysts. Amorphous materials can serve as an effective support matrix to form unique crystalline‐amorphous interfaces and modulate the electronic structure of active metals. However, robust synthetic strategies for precise structural control remain underdeveloped. Here, we report the laser‐shocked synthesis of heterostructures including bimetallic CuNi, CuFe, CuCo, and medium‐entropy CuFeCoNi heterostructures, where crystalline metal nanoparticles are anchored on amorphous hydroxide supports. The heterostructures are characterized by an interfacial electronic distribution that improves catalytic activities. With CuNi as an example for nitrate reduction reaction, the laser‐engineered heterophase CuNi achieves an NH 3 production rate of 92.18 mg/h/mg cat with 98.6% Faradaic efficiency (FE), substantially superior to standalone crystalline CuNi or amorphous CuNi hydroxide. The CuNi heterostructure maintains a stable FE(NH 3 ) of ∼90% up to 80 h while improving current density from 75 to 120 mA/cm 2 due to the robust amorphous layer and dynamic amorphous/crystalline reconstruction. In situ characterization and theoretical calculations reveal that the amorphous/crystalline interface regulates the balance between reactive hydrogen species and reaction intermediates, effectively suppressing the competing hydrogen evolution and promoting cascade nitrate‐to‐nitrite and nitrite‐to ammonia conversion. This work provides a general and viable strategy for producing high‐performance supported catalysts.
HIF-1α drives distinct aspects of hypoxia-induced glucose metabolism in intestinal epithelial cells
The ELIMINATE trial: A phase II/III randomized trial evaluating omission of radiotherapy to regional lymphatics in pN0/N1 neck for oral cavity carcinomas.
TPS243 Background: Postoperative radiotherapy (PORT) improves locoregional control in oral cavity squamous cell carcinoma (OCSCC) with adverse pathological features. However, irradiation of elective regional lymphatics contributes substantially to dysphagia and long-term toxicity. In adequately dissected pN0–pN1 necks, the oncologic benefit of regional nodal irradiation remains uncertain. ELIMINATE evaluates whether omission of regional PORT maintains regional control while reducing treatment-related morbidity. Methods: ELIMINATE is an open-label, multicenter, randomized phase II/III non-inferiority trial enrolling 396 patients with resected pT1–4 OCSCC and pathological pN0–pN1 disease after adequate neck dissection (≥12 nodes in at least one hemi-neck). Eligible patients have high-risk features (positive/close margin ≤5 mm, lymphovascular invasion, perineural invasion, or pT3–4 disease) and Karnofsky performance status ≥70. Patients are randomized 1:1, stratified by T stage (T1–2 vs T3–4), nodal status (pN0 vs pN1), and margin status (free vs involved), to: Arm A (standard): IMRT to primary tumor bed and regional lymphatics (60–66 Gy in 30–33 fractions) ± weekly cisplatin (40 mg/m²) for margin-positive disease.Arm B (experimental): IMRT or brachytherapy to the primary tumor bed alone, omitting elective nodal irradiation. The primary endpoint is 2-year regional control. Secondary endpoints include locoregional control, disease-free survival, overall survival, acute toxicity (RTOG), late toxicity (LENT-SOMA), swallowing function (MDADI), and quality of life (EORTC QLQ-C30 and H&N35).The trial is powered (80%, one-sided α=0.05) to test non-inferiority with a 5% absolute margin, assuming 2-year regional control of 85% with standard PORT versus 80% with omission, allowing 10% attrition (n=396). Accrual is ongoing across participating tertiary centers. Treatment compliance, dosimetric data, toxicity, and oncologic outcomes will be reported at analysis. ELIMINATE is the first adequately powered randomized study evaluating omission of elective nodal irradiation in both pN0 and pN1 OCSCC following adequate dissection. If non-inferiority is demonstrated, this strategy may safely reduce radiation volumes, decrease swallowing morbidity, and redefine postoperative standards in selected patients. Clinical trial information: CTRI/2022/02/040311 .
Postoperative ICU outcomes and predictors of morbidity and mortality in cancer patients after oncosurgery: A retrospective study from a tertiary care center in India.
345 Background: Surgery remains the cornerstone of curative treatment for many malignancies, yet, postoperative complications remain disproportionately higher in LMIC setting. Rescuing patients who sustain a major complication post oncosurgery, from dying has become an important focus in quality improvement post onco-surgery. Therefore, this study was designed to assess factors and variables linked with morbidity and mortality in patients admitted to critical care facility after oncosurgery so that measures to curb and minimize them can be undertaken. Methods: Study design: Retrospective Observational Study. Setting: Single centre. Duration: Data collection from 1st January 2018-31st December 2023. Primary objective: To assess the mortality rates and identify predictors of mortality in cancer patients admitted to ICU post onco-surgery. Secondary objective: To assess postoperative complications and identify predictors of morbidity. Inclusion criteria: 1. 18 years or older. 2. Patients diagnosed with solid organ malignancy undergoing onco-surgery for the same. Exclusion criteria: 1. Age <18 years. 2. Non surgical patients with solid organ malignancy admitted to ICU. 3. Patients with haematological malignancies admitted to ICU. Data collection: Medical records of ICU admissions between January 1st 2018-December 31st 2023 were retrospectively screened to identify patients fulfilling the inclusion criteria. 69 variables pertaining to the perioperative period were collected. Postoperative 30-day mortality was recorded. Postoperative morbidity was graded using Clavien Dindo classification. Statistical analysis: A logistic (univariate and multivariate) regression analysis was performed to identify independent predictors of morbidity and mortality. A p value <0.05 was considered statistically significant. Missing data were handled using complete case analysis. No imputation was performed. Ethical clearance: From Institute Ethics Committee of All India Institute of Medical Sciences, New Delhi. The trial was registered at CTRI (Clinical Trials Registry of India) portal. Results: Major postoperative morbidity (Clavien Dindo>/III) occurred in 28.6% of patients, while 30-day mortality was 8.9%. Independent predictors of mortality included surgical site infection (SSI) (OR 2.84, 95% CI 1.98-4.07; P<0.001), preoperative deranged RFTs (OR 2.32; 95% CI1.66-3.22; p<0.05), ASA II-IV (OR 1.94; 95% CI 1.39-2.71; p<0.001), re-do surgeries/reexplorations (OR 2.47; 95% CI 1.61-3.79; p<0.05) and type 2 diabetes mellitus (OR 1.76; 95% CI 1.21-2.56; P<0.05). Conclusions: Postoperative cancer patients requiring ICU admission represent a high risk cohort. Optimization of modifiable risk factors and strengthened perioperative surveillance may improve outcomes in this vulnerable population.